Larvol Delta - BOLDPo05-as-an-AddOn-Treatment-of-Subjects-With-Newly-Diagnosed-Type-1-Diabetes-Mellitus

BOL-DP-o-05 - BOL Pharma

http://clinicaltrials.gov/ct2/show/NCT04102202

Mar 24, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next